[go: up one dir, main page]

MA27586A1 - Systemes de distribution pharmaceutiques et/ou cosmetiques topiques - Google Patents

Systemes de distribution pharmaceutiques et/ou cosmetiques topiques

Info

Publication number
MA27586A1
MA27586A1 MA28450A MA28450A MA27586A1 MA 27586 A1 MA27586 A1 MA 27586A1 MA 28450 A MA28450 A MA 28450A MA 28450 A MA28450 A MA 28450A MA 27586 A1 MA27586 A1 MA 27586A1
Authority
MA
Morocco
Prior art keywords
formulations
distribution systems
topical pharmaceutical
dispense
active ingredient
Prior art date
Application number
MA28450A
Other languages
English (en)
Inventor
Embil Koral
Nacht Sergio
Original Assignee
Edko Trading Representation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edko Trading Representation filed Critical Edko Trading Representation
Publication of MA27586A1 publication Critical patent/MA27586A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
    • B65D81/3283—Cylindrical or polygonal containers, e.g. bottles, with two or more substantially axially offset, side-by-side compartments for simultaneous dispensing
    • B65D81/3288—Cylindrical or polygonal containers, e.g. bottles, with two or more substantially axially offset, side-by-side compartments for simultaneous dispensing composed of two or more separate containers joined to each other
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)

Abstract

L'invention concerne un produit pharmaceutique et/ou cosmétique comprenant une première et une seconde formulation contenant un principe actif, destinées à être administré de manière topique à un patient. Ledit système comprend des moyens de stockage, les formulations étant conservées séparément avant d'être distribuées, des moyens de distribution qui permettent de distribuer lesdites formulations contenues dans les moyens de stockage. Ledit produit est caractérisé en ce que (i) un principe actif dans au moins une des formulations est contenu dans au moins un système d'administration polymère (par exemple un système d'administration micro-éponge) et (ii) les deux formulations comprennent des bases support à base d'eau (par exemple aqueux) présentant sensiblement la même lipophilie. L'invention concerne, de plus, un système d'administration double ou à chambres multiples, conçu pour distribuer lesdites formulations, et qui comprend un dispositif de fermeture amovible, par exemple un couvercle. Ledit couvercle empêche les formulations d'être distribuées accidentellement par un orifice (s) de distribution et peut également réduire l'exposition à l'air desdits orifices (s). Les produits de l'invention conviennent en particulier à des formulations d'administration, destinées à traiter des états pathologiques dermatologiques tels que l'acné, en particulier des formulations, dans lesquelles les principes actifs présentent des limites de stabilité, lorsqu'ils sont en combinaison, par exemple ceux qui comprennent des agents antibactériens oxydants (par exemple le peroxydede dibenzoyle) et les antibiotiques.
MA28450A 2003-01-23 2005-08-23 Systemes de distribution pharmaceutiques et/ou cosmetiques topiques MA27586A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0301577.3A GB0301577D0 (en) 2003-01-23 2003-01-23 Topical pharmaceutical and/or cosmetic dispense systems

Publications (1)

Publication Number Publication Date
MA27586A1 true MA27586A1 (fr) 2005-10-03

Family

ID=9951680

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28450A MA27586A1 (fr) 2003-01-23 2005-08-23 Systemes de distribution pharmaceutiques et/ou cosmetiques topiques

Country Status (18)

Country Link
US (1) US20040157766A1 (fr)
EP (1) EP1589945B1 (fr)
JP (1) JP4898423B2 (fr)
KR (1) KR101224065B1 (fr)
CN (1) CN1764437B (fr)
AT (1) ATE509616T1 (fr)
AU (1) AU2004206101B2 (fr)
BR (1) BRPI0406911A (fr)
CA (1) CA2514019C (fr)
DK (1) DK1589945T3 (fr)
EA (1) EA008813B1 (fr)
GB (1) GB0301577D0 (fr)
HK (1) HK1088540A1 (fr)
MA (1) MA27586A1 (fr)
MX (1) MXPA05007785A (fr)
NZ (1) NZ541370A (fr)
WO (1) WO2004064803A1 (fr)
ZA (1) ZA200505925B (fr)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820186B2 (en) * 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
CA2586798A1 (fr) * 2004-11-09 2006-05-18 Imaginative Research Associates, Inc. Solutions de retinoides et formulations preparees a partir de ces dernieres
WO2007017901A2 (fr) * 2005-06-08 2007-02-15 Khandelwal Sanjeev Preparation a dispersion de nanoparticules d'argent
AR054805A1 (es) * 2005-06-29 2007-07-18 Stiefel Laboratories Composiciones topicas para el tratamiento de la piel
EP2431089A1 (fr) 2005-08-02 2012-03-21 Sol-Gel Technologies Ltd. Revêtement d'oxyde métallique d'ingrédients insolubles dans l'eau
EP1764104B1 (fr) * 2005-09-16 2008-08-13 Italfar Società a Responsabilità Limitata Composition pharmaceutique à base de sucralfate, de glycine, d'acétate d'aluminium et de vitamines pour la guérison des plaies
US8147815B2 (en) * 2005-12-16 2012-04-03 Celmatrix Corporation Topical administration carrier composition and therapeutic formulations comprising same
WO2007092312A2 (fr) * 2006-02-03 2007-08-16 Stiefel Laboratories, Inc. Compositions pour traitement cutane topique
US8158109B2 (en) 2006-03-31 2012-04-17 Stiefel Research Australia Pty Ltd Foamable suspension gel
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
MX2009000053A (es) * 2006-07-12 2009-02-23 Controlled Therapeutics Sct Polimero para el suministro de medicamentos con sal clorhidrato de clindamicina.
FR2903603B1 (fr) * 2006-07-13 2009-03-20 Galderma Res & Dev S N C Snc Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne
US8080537B2 (en) * 2006-07-13 2011-12-20 Galderma Research & Development Combinations of adapalene and benzoyl peroxide for treating acne lesions
JP2009545530A (ja) * 2006-07-24 2009-12-24 アンコル インターナショナル コーポレイション デリバリーシステムおよびその製造方法
MXPA06008988A (es) * 2006-08-08 2008-02-07 Fernando Ahumada Ayala Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas).
US7604814B2 (en) * 2006-08-29 2009-10-20 Karykion Inc. Method of removing ticks from the epidermal tissue of humans and other mammals
US8323672B2 (en) 2006-08-29 2012-12-04 Karykion Corporation Method of removing ticks from the skin and reducing the risk of bites
GB0618697D0 (en) * 2006-09-22 2006-11-01 Syntopix Ltd Formulations
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
WO2008093346A2 (fr) 2007-02-01 2008-08-07 Sol-Gel Technologies Ltd. Compositions d'application topique comprenant un peroxyde et un rétinoïde
CA2824842C (fr) 2007-02-01 2016-10-11 Sol-Gel Technologies Ltd. Methode de preparation de particules comprenant un enrobage d'oxyde metallique, et particules enrobees d'oxyde metallique
US20080188446A1 (en) * 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
US7726487B2 (en) * 2007-02-09 2010-06-01 Mcneil-Ppc, Inc. Complementary personal lubricant compositions
US20080287373A1 (en) * 2007-05-17 2008-11-20 Popp Karl F Topical skin treating kits
US8275441B2 (en) * 2007-11-02 2012-09-25 Tyco Healthcare Group Lp Electrodes possessing change indicator
KR20100125278A (ko) * 2008-02-01 2010-11-30 암콜 인터내셔널 코포레이션 향상된 피부 미백 조성물
KR20110021888A (ko) * 2008-05-16 2011-03-04 갈데르마 리써어치 앤드 디벨로프먼트 여드름 관련 질환을 치료하기 위한 치료 요법
EP2291180A1 (fr) * 2008-05-30 2011-03-09 Galderma Research & Development Compositions depigmentantes anhydres comprenant, au sein de la phase grasse un derive phenolique solubilise et un retinoide
US7740886B1 (en) * 2008-07-11 2010-06-22 Sara Vargas Bedsore treatment ointment
CA2736884A1 (fr) 2008-09-17 2010-03-25 Patrick D. Mcgrath Procedes et compositions de pate de sucralfate antimicrobienne
WO2010047831A1 (fr) * 2008-10-23 2010-04-29 Nycomed Us Inc. Formulations de gel de métronidazole stables
EA201100645A1 (ru) * 2009-01-05 2011-10-31 Сол-Джел Текнолоджиз Лтд. Композиции для местного применения, содержащие активные агенты с покрытием
CN102281957B (zh) 2009-01-16 2014-02-26 高露洁-棕榄公司 包括泵收容附件的分配容器
WO2011101868A2 (fr) * 2010-02-18 2011-08-25 Helios Pharmaceuticals Private Limited Préparations pharmaceutiquement stables contenant de la clindamycine et du peroxyde de benzoyle, et méthode associée
US20120064135A1 (en) * 2010-09-15 2012-03-15 Norac Pharma Benzoyl Peroxide Composition, Methods for Making Same, and Pharmaceutical or Cosmetic Formulations Comprising Same, and Uses Thereof
CN102475681A (zh) * 2010-11-23 2012-05-30 天津金耀集团有限公司 治疗皮肤病的分离式水混悬剂药物
CN102600205B (zh) * 2011-01-19 2013-06-05 杨光明 一种治疗寻常性痤疮的“锌红过氧化苯甲酰”凝胶及其制备方法
AU2012275714A1 (en) * 2011-06-30 2014-01-30 Allergan, Inc. Retinoid topical compositions and methods for treating skin conditions
RU2015101177A (ru) * 2012-07-05 2016-08-27 Вм. Ригли Джр. Компани Жевательная резинка и её основа на основе микрочастиц сшитых полимеров
CN102961250B (zh) * 2012-10-10 2014-12-10 江苏山信药业有限公司 一种多组份容器及治疗痤疮的外用制剂
ES2861431T3 (es) * 2012-11-27 2021-10-06 Sol Gel Tech Ltd Composiciones para el tratamiento de la rosácea
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
US9474720B2 (en) 2013-11-04 2016-10-25 BioPharmX, Inc. Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
PH12014000195B1 (en) * 2014-07-10 2023-06-30 D&L Ind Inc Composition of medium chain triglycerides containing substantial amount of lauric acid
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method
MX2017003003A (es) * 2017-03-08 2018-09-07 Centro Int De Cosmiatria S A P I De C V Composición y método para el tratamiento tópico del acné severo.
MX2018001546A (es) * 2018-02-06 2019-08-07 Centro Int De Cosmiatria S A P I De C V Formulacion y metodo para el tratamiento de la alopecia androgenica.
JP6811213B2 (ja) * 2018-07-03 2021-01-13 ソル − ゲル テクノロジーズ リミテッド 酒さの治療のための組成物
US20220175802A1 (en) * 2019-03-19 2022-06-09 Sol-Gel Technologies Ltd. Combination of minocycline and benzoyl peroxide and method of use thereof
EP3946183A4 (fr) * 2019-03-28 2022-12-28 Tearclear Corp. Dispositifs et procédés de régulation de flux de formulations ophtalmiques
US11638759B2 (en) 2019-08-13 2023-05-02 Darlene E. McCord Non-activated, amorphous, pH neutral, two-part bedside-ready clay delivery system that treats pathogen infections in humans and animals
WO2022040431A1 (fr) * 2020-08-19 2022-02-24 Cytosorbents Corporation Traitement thérapeutique et cosmétique des plaies
US12213993B2 (en) 2021-10-25 2025-02-04 Darlene E. McCord Coated medicinal clay compositions, pharmaceutical compositions, and delivery of cation sources and methods of use thereof
WO2023112664A1 (fr) * 2021-12-14 2023-06-22 ロート製薬株式会社 Composition pharmaceutique pour application externe contenant du peroxyde de benzoyle

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3535422A (en) * 1968-03-11 1970-10-20 Stiefel Laboratories Stable benzoyl peroxide composition
US4056611A (en) * 1973-04-16 1977-11-01 Stiefel Laboratories, Inc. Therapeutic composition
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US4497794A (en) * 1980-12-08 1985-02-05 Dermik Laboratories, Inc. Erythromycin/benzoyl peroxide composition for the treatment of acne
US4318907A (en) * 1978-04-04 1982-03-09 Westwood Pharmaceuticals, Inc. Method for treating acne vulgaris and compositions useful for that purpose
US4228163A (en) * 1979-03-30 1980-10-14 Dermik Laboratories Method for treating pseudofolliculitis barbae
US4387107A (en) * 1979-07-25 1983-06-07 Dermik Laboratories, Inc. Stable benzoyl peroxide composition
IT1210608B (it) * 1980-12-08 1989-09-14 Rorer Int Overseas Composizione per il trattamento topico dell'acne
US4692329A (en) * 1980-12-08 1987-09-08 William H. Rorer, Inc. Erythromycin/benzoyl peroxide antiacne compositions
US4411893A (en) * 1981-08-14 1983-10-25 Minnesota Mining And Manufacturing Company Topical medicament preparations
US4607101A (en) * 1981-08-27 1986-08-19 Jaye-Boern Laboratories, Inc. Method of treating acne vulgaris with a composition containing carbamide peroxide
WO1983002558A1 (fr) * 1981-11-09 1983-08-04 Gail Sansone Bazzano Utilisation de retinoides et minoxydile (2,4,-diamino-6-piperidino-pyrimidine-3-oxyde) pour ameliorer le taux de croissance des cheveux et traiter certains types d'alopecies chez l'homme
US4923900A (en) * 1985-01-24 1990-05-08 Board Of Regents, The University Of Texas System Therapeutic compositions containing benzoyl peroxide
US4690825A (en) * 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen
US5446028A (en) * 1985-12-12 1995-08-29 Dermik Laboratories, Inc. Anti-acne method and composition
US5145675A (en) * 1986-03-31 1992-09-08 Advanced Polymer Systems, Inc. Two step method for preparation of controlled release formulations
US5879716A (en) * 1985-12-18 1999-03-09 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of benzoyl peroxide
US5955109A (en) * 1985-12-18 1999-09-21 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of retinoic acid
ZA886284B (en) * 1987-08-31 1990-04-25 Advanced Polymer Systems Inc Controlled release formulations
US4873091A (en) * 1988-05-23 1989-10-10 Advanced Polymer Systems, Inc. Controlled release formulating employing resilient microbeads
US4962170A (en) * 1989-08-31 1990-10-09 Dow Corning Corporation Method of making highly absorptive polymers
US4962133A (en) * 1989-09-05 1990-10-09 Dow Corning Corporation Method of making highly adsorptive copolymers
CA2015111A1 (fr) * 1990-04-23 1991-10-23 Tom Y. Woo Nouveau distributeur a deux compartiments pour substances fluides, mi-fluides ou mi-solides
US5256400A (en) * 1991-12-04 1993-10-26 Advanced Polymer Systems, Inc. Pressurized product delivery systems
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
US6117843A (en) * 1992-02-18 2000-09-12 Lloyd J. Baroody Compositions for the treatment of acne containing clindamycin and benzoyl peroxide
US5356040A (en) * 1992-03-31 1994-10-18 Maplast S.R.L. Container particulary for multicomponent products
US5466446A (en) * 1994-02-16 1995-11-14 Stiefel Laboratories, Inc. Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof
US5837790A (en) * 1994-10-24 1998-11-17 Amcol International Corporation Precipitation polymerization process for producing an oil adsorbent polymer capable of entrapping solid particles and liquids and the product thereof
US5712358A (en) * 1995-06-07 1998-01-27 Amcol International Corporation Process for producing an oil sorbent copolymer and the product thereof
JPH09226852A (ja) * 1996-02-28 1997-09-02 Cci Corp 塗布容器
JPH11222272A (ja) * 1998-02-02 1999-08-17 Tombow Pencil Co Ltd 液体のり容器
US6013637A (en) * 1998-06-12 2000-01-11 Dermik Laboratories Inc. Anti-acne method and composition
US6110446A (en) * 1998-10-05 2000-08-29 Colgate Palmolive Company Dual component antiplaque and tooth whitening composition
US6007264A (en) * 1998-12-02 1999-12-28 Felix Investments, Llc Integral package applicator
CA2309373A1 (fr) * 1999-05-27 2000-11-27 Johnson & Johnson Consumer Companies, Inc. Preparations topiques nouvelles
US7758888B2 (en) * 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
EP2324812A3 (fr) * 2000-04-21 2012-09-19 Sol-Gel Technologies Ltd. Composition à stabilité de préparation accrue et administration d'ingredients actifs topiques
AU2001275201A1 (en) * 2000-06-02 2001-12-11 Dermik International Holding Inc. Acne-treating composition
JP4580524B2 (ja) * 2000-09-12 2010-11-17 株式会社日本点眼薬研究所 フィルター付き吐出容器
US6462025B2 (en) * 2000-12-12 2002-10-08 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US6544562B2 (en) * 2001-06-25 2003-04-08 Blistex Inc. Acne treatment including dual-package system

Also Published As

Publication number Publication date
CA2514019A1 (fr) 2004-08-05
KR101224065B1 (ko) 2013-01-21
JP4898423B2 (ja) 2012-03-14
ATE509616T1 (de) 2011-06-15
EA008813B1 (ru) 2007-08-31
KR20050105442A (ko) 2005-11-04
EP1589945A1 (fr) 2005-11-02
WO2004064803A1 (fr) 2004-08-05
EP1589945B1 (fr) 2011-05-18
AU2004206101A2 (en) 2004-08-05
ZA200505925B (en) 2006-11-29
DK1589945T3 (da) 2011-09-05
JP2006519178A (ja) 2006-08-24
GB0301577D0 (en) 2003-02-26
AU2004206101A1 (en) 2004-08-05
HK1088540A1 (en) 2006-11-10
CN1764437A (zh) 2006-04-26
NZ541370A (en) 2008-08-29
BRPI0406911A (pt) 2006-01-03
US20040157766A1 (en) 2004-08-12
CN1764437B (zh) 2010-05-12
MXPA05007785A (es) 2006-05-04
CA2514019C (fr) 2012-02-28
AU2004206101B2 (en) 2010-06-24
EA200501107A1 (ru) 2006-02-24

Similar Documents

Publication Publication Date Title
MA27586A1 (fr) Systemes de distribution pharmaceutiques et/ou cosmetiques topiques
DE60005819D1 (de) Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
SE0003449D0 (sv) Anticancer compositions
NO953278D0 (no) Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette
MXPA05010565A (es) Sistemas de suminsitro de farmacos que comprenden un ingrediente activo encapsulado.
EA200401252A1 (ru) Микрочастицы лекарственных веществ
WO2004105702A3 (fr) Compositions pharmaceutiques expansibles et procedes de traitement d'un trouble donne
WO2005046640A3 (fr) Plateforme d'administration de medicaments a sites multiples
WO2004054542A3 (fr) Systeme d'administration de medicaments par voie orale
WO2006113505A3 (fr) Systemes d'apport de substances pharmaceutiques destines a des medicaments hydrophobes et compositions comprenant ces derniers
DE602004026173D1 (de) Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
NZ594618A (en) Transdermal pharmaceutical preparations
DE60004797D1 (de) Arzneimittel mit verzögerter wirkstoffabgabe enthaltend isoquercetin und ascorbinsäure
ATE311904T1 (de) Halbfester verabreichungsträger und arzneimittel
NO20073575L (no) Farmasoytiske sammensetninger for behandling av cellulitt
WO2002034240A3 (fr) Formulations a liberation retardee et prolongee et procede d'utilisation
WO2006060325A3 (fr) Formulations enrobees d'administration de medicaments
CA2185883A1 (fr) Utilisation de dimeticone en tant que systeme vehiculaire et/ou d'apport medicamenteux
MA26788A1 (fr) COMPOSITIONS PHARMACEUTIQUES DESTINÉES à L'ADMINISTRATION PAR VOIE ORALE DE PHLOROGLUCINOL ET LEUR PRÉPARATION
BR9806303A (pt) Sistema de distrituição de droga termoformado, e, unidade de dosagem
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao
MY141008A (en) Oral formulations of deoxypeganine and their uses
BRPI0412010A (pt) sistema de distribuição de drogas tópicas
MX2020006886A (es) Sistema para suministro de medicamento.
AR029096A1 (es) Combinacion de sustancias activas que contiene montirelina y un compuesto de efecto opioide, medicamentos y formulaciones medicamentosas que contienen dicha combinacion y su uso para la preparacion de medicamentos para tratamiento del dolor